Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Monk

Showing results (191-200 of 738) with videos related to

Pageof 74
Sort By:
Gynecologic Oncology|January 1, 1997
Photodynamic therapy using topically applied dihematoporphyrin ether in the treatment of cervical intraepithelial neoplasiaB J Monk, C Brewer, K VanNostrand, et al.
European Journal of Gynaecological Oncology|January 31, 2014
High pathologic misdiagnosis of cervical adenocarcinoma in situS M Jordan, D M Chase, T Watanabe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 19, 2014
Factors associated with grade 3 or 4 treatment-related toxicity in women with advanced or recurrent cervical cancer: an exploratory analysis of NRG Oncology/Gynecologic Oncology Group trials 179 and 204Dana M Chase, James Kauderer, Lari Wenzel, et al.
British Journal of Anaesthesia|October 1, 1982
Chronic exposure of rats to enflurane 200 p.p.m.: no evidence of toxicity or teratogenicityC J Green, S J Monk, J F Knight, et al.
Gynecologic Oncology|July 4, 2006
Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: a Gynecologic Oncology Group studySteven E Waggoner, Kathleen M Darcy, Barbara Fuhrman, et al.
Gynecologic Oncology|October 15, 2011
A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: a gynecologic oncology group studyBradley J Monk, John A Blessing, Daron G Street, et al.
Gynecologic Oncology|February 1, 1994
Open interstitial brachytherapy for the treatment of local-regional recurrences of uterine corpus and cervix cancer after primary surgeryB J Monk, J L Walker, K Tewari, et al.
The West Virginia Medical Journal|June 1, 1994
Results of cancer information assessment of high school students in West VirginiaS J Jubelirer, M F Blanton, J Zhang, et al.
Cancer|March 19, 2008
Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group studyJohn K Chan, Chunqiao Tian, Bradley J Monk, et al.
Gynecologic Oncology|January 28, 2015
Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2Lindsey E Minion, Jill S Dolinsky, Dana M Chase, et al.
Pageof 74

Showing results (191-200 of 738) with videos related to

Sort By:
Pageof 74
Gynecologic Oncology|January 1, 1997
Photodynamic therapy using topically applied dihematoporphyrin ether in the treatment of cervical intraepithelial neoplasiaB J Monk, C Brewer, K VanNostrand, et al.
European Journal of Gynaecological Oncology|January 31, 2014
High pathologic misdiagnosis of cervical adenocarcinoma in situS M Jordan, D M Chase, T Watanabe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 19, 2014
Factors associated with grade 3 or 4 treatment-related toxicity in women with advanced or recurrent cervical cancer: an exploratory analysis of NRG Oncology/Gynecologic Oncology Group trials 179 and 204Dana M Chase, James Kauderer, Lari Wenzel, et al.
British Journal of Anaesthesia|October 1, 1982
Chronic exposure of rats to enflurane 200 p.p.m.: no evidence of toxicity or teratogenicityC J Green, S J Monk, J F Knight, et al.
Gynecologic Oncology|July 4, 2006
Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: a Gynecologic Oncology Group studySteven E Waggoner, Kathleen M Darcy, Barbara Fuhrman, et al.
Gynecologic Oncology|October 15, 2011
A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: a gynecologic oncology group studyBradley J Monk, John A Blessing, Daron G Street, et al.
Gynecologic Oncology|February 1, 1994
Open interstitial brachytherapy for the treatment of local-regional recurrences of uterine corpus and cervix cancer after primary surgeryB J Monk, J L Walker, K Tewari, et al.
The West Virginia Medical Journal|June 1, 1994
Results of cancer information assessment of high school students in West VirginiaS J Jubelirer, M F Blanton, J Zhang, et al.
Cancer|March 19, 2008
Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group studyJohn K Chan, Chunqiao Tian, Bradley J Monk, et al.
Gynecologic Oncology|January 28, 2015
Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2Lindsey E Minion, Jill S Dolinsky, Dana M Chase, et al.
Pageof 74